Prevalence of COVID-19 in children affected by allergic rhinoconjunctivitis and asthma: results from the second "SIAIP rhinosinusitis and conjunctivitis committee" survey.
Giulia BrindisiAnna Maria ZicariGiuseppe Fabio ParisiLucia DiaferioCristiana IndolfiGiuseppe MarcheseDaniele Giovanni GhiglioniGiuseppina Rosaria UmanoAngela KlainGian Luigi MarsegliaMichele Miraglia Del GiudicePublished in: Italian journal of pediatrics (2022)
Allergic rhinoconjunctivitis and asthma, if under control, did not represent risk factors for the susceptibility to SARS CoV2. Therefore, it is strongly recommended to continue therapies during COVID-19 outbreak, according to the international guidelines. However, being COVID-19 a new disease, actual knowledge will undergo continuous improvements over time.